Suyash Prasad
Director/Board Member bij National Pku Alliance
Profiel
Suyash Prasad is currently the Director at National Pku Alliance, a Member at The Royal College of Physicians, and a Member at The Royal College of Paediatrics & Child Health.
He is also the Principal at Dr. Prasad Consulting LLC since 2019.
Previously, he worked as the Senior Group Medical Director-Development Sciences at BioMarin Pharmaceutical, Inc. from 2010 to 2014, Director-Global Medical Affairs at Genzyme Corp.
from 2009 to 2010, and Senior Clinical Research Physician at Eli Lilly & Co. Ltd.
He also served as the Chief Medical Officer & Senior Vice President at Astellas Gene Therapies, Inc. from 2014 to 2019.
In 2020, he joined Taysha Gene Therapies, Inc. as the Chief Medical Officer, a position he held until 2023.
Dr. Prasad holds a doctorate from Newcastle University and a graduate degree from King's College London.
Actieve functies van Suyash Prasad
| Bedrijven | Functie | Begin |
|---|---|---|
| The Royal College of Physicians | Corporate Officer/Principal | - |
| The Royal College of Paediatrics & Child Health | Corporate Officer/Principal | - |
| National Pku Alliance | Director/Board Member | - |
| Suyash Prasad Consulting LLC | Corporate Officer/Principal | 01-10-2019 |
Eerdere bekende functies van Suyash Prasad
| Bedrijven | Functie | Einde |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 12-01-2023 |
| AUDENTES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30-06-2019 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-02-2014 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01-12-2010 |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Suyash Prasad
| Newcastle University | Doctorate Degree |
| King's College London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
| National Pku Alliance | |
| Suyash Prasad Consulting LLC |
